Patent In $41M Contact Lens Suit Invalid: Re-Exam

Law360, New York (October 9, 2008, 12:00 AM EDT) -- The contact lens patent at the center of a lawsuit between Novartis AG unit CIBA Vision Corp. and Rembrandt Vision Technologies LP, which resulted in a $41 million verdict against CIBA earlier this year, has been found to be invalid for obviousness after a re-examination.

The preliminary results of the re-examination found that the patent held by Rembrandt, which a jury in the U.S. District Court for the Eastern District of Texas found in February that CIBA had infringed, was unpatentable in view of several earlier...
To view the full article, register now.